Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-25.27 Insider Own22.97% Shs Outstand13.36M Perf Week-3.41%
Market Cap37.81M Forward P/E- EPS next Y-1.70 Insider Trans401.84% Shs Float10.29M Perf Month15.98%
Income-40.86M PEG- EPS next Q-0.50 Inst Own52.57% Short Float3.64% Perf Quarter-7.21%
Sales1.38M P/S27.40 EPS this Y36.89% Inst Trans-23.99% Short Ratio6.01 Perf Half Y-28.72%
Book/sh1.40 P/B2.02 EPS next Y28.17% ROA-51.95% Short Interest0.37M Perf Year-35.68%
Cash/sh0.42 P/C6.78 EPS next 5Y- ROE-132.29% 52W Range2.08 - 4.86 Perf YTD13.20%
Dividend Est.- P/FCF- EPS past 5Y14.72% ROI-210.26% 52W High-41.82% Beta0.84
Dividend TTM- Quick Ratio0.78 Sales past 5Y16.25% Gross Margin-60.27% 52W Low36.06% ATR (14)0.18
Dividend Ex-Date- Current Ratio0.78 EPS Y/Y TTM-92.98% Oper. Margin-1580.32% RSI (14)51.18 Volatility6.97% 6.99%
Employees46 Debt/Eq0.20 Sales Y/Y TTM- Profit Margin-2956.66% Recom1.67 Target Price4.42
Option/ShortNo / Yes LT Debt/Eq0.15 EPS Q/Q-380.86% Payout- Rel Volume0.07 Prev Close2.83
Sales Surprise-49.71% EPS Surprise7.81% Sales Q/Q-40.74% EarningsMay 15 AMC Avg Volume62.27K Price2.83
SMA201.72% SMA500.66% SMA200-7.90% Trades Volume4,626 Change-0.16%
Date Action Analyst Rating Change Price Target Change
May-24-22Downgrade Stephens Overweight → Equal-Weight
Mar-14-22Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Jan-07-22Initiated Stephens Overweight $3.10
Jan-06-22Resumed Piper Sandler Overweight $3.10
Mar-17-21Resumed Needham Buy $8
Jan-07-21Upgrade The Benchmark Company Speculative Buy → Buy $6
Dec-16-20Upgrade Piper Sandler Neutral → Overweight $2 → $4
Nov-30-20Initiated BTIG Research Buy $5
Nov-10-20Initiated KeyBanc Capital Markets Overweight $5
Jul-30-20Reiterated The Benchmark Company Speculative Buy $7 → $6
May-15-24 08:55PM
May-13-24 08:00AM
May-07-24 09:19AM
Apr-12-24 10:52AM
06:00AM Loading…
Apr-11-24 09:46PM
Apr-09-24 04:05PM
Jan-16-24 08:00AM
Dec-06-23 08:00AM
Nov-09-23 08:27AM
Nov-03-23 08:30AM
Sep-18-23 08:00AM
08:00AM Loading…
Sep-06-23 08:00AM
Aug-28-23 08:30AM
Aug-10-23 07:00AM
Aug-09-23 08:00AM
Aug-08-23 08:30AM
Aug-03-23 08:00AM
Jul-25-23 09:08AM
Jul-24-23 01:35PM
Jun-27-23 08:30AM
Jun-01-23 04:15PM
May-11-23 08:00AM
Apr-27-23 04:59PM
Apr-18-23 08:45AM
Apr-12-23 04:15PM
Apr-07-23 08:24AM
08:00AM Loading…
Apr-03-23 08:00AM
Mar-31-23 05:00PM
Mar-29-23 04:01PM
Mar-15-23 04:01PM
Mar-02-23 09:00AM
Feb-22-23 08:00AM
Dec-16-22 08:19AM
Nov-30-22 06:05PM
Nov-10-22 04:30PM
Oct-27-22 04:01PM
Oct-06-22 08:00AM
Sep-07-22 08:00AM
Aug-31-22 04:01PM
Aug-30-22 04:27PM
Aug-24-22 08:00AM
Aug-10-22 04:05PM
Aug-03-22 04:01PM
Aug-01-22 11:33AM
Jul-27-22 04:01PM
Jul-13-22 08:00AM
Jul-06-22 08:00AM
Jun-22-22 08:00AM
Jun-15-22 07:15AM
May-26-22 05:00PM
May-11-22 04:05PM
May-05-22 08:00AM
Apr-28-22 04:01PM
Apr-27-22 04:30PM
Apr-22-22 09:26AM
Apr-13-22 10:01PM
Apr-11-22 08:00AM
Mar-28-22 08:00AM
Mar-10-22 04:05PM
Mar-01-22 04:05PM
Feb-21-22 07:26AM
Feb-10-22 08:00AM
Jan-18-22 04:05PM
Jan-06-22 09:43AM
Jan-04-22 08:00AM
Dec-09-21 06:00PM
Dec-08-21 08:00AM
Dec-06-21 08:00AM
Dec-02-21 08:00AM
Nov-22-21 06:14AM
Nov-09-21 04:05PM
Nov-04-21 08:00AM
Nov-02-21 03:02PM
Oct-27-21 08:00AM
Oct-26-21 04:05PM
Oct-08-21 09:46AM
Oct-07-21 08:00AM
Sep-30-21 08:00AM
Sep-20-21 11:35AM
Sep-16-21 08:00AM
Sep-13-21 08:00AM
Sep-07-21 04:05PM
Aug-23-21 09:13AM
Aug-18-21 08:49AM
Aug-17-21 08:00AM
Aug-10-21 04:01PM
Aug-09-21 08:00AM
Aug-03-21 03:00PM
Jul-27-21 10:35AM
Jul-08-21 05:34AM
OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BROADWOOD PARTNERS, L.P.10% OwnerApr 11 '24Buy2.922,420,0007,057,6884,929,066Apr 15 07:21 PM
Arno AndrewDirectorApr 11 '24Buy2.9533,89899,99969,054Apr 15 06:02 AM
Riggs JoshCEO and PresidentApr 11 '24Buy2.953,39010,0003,505Apr 15 06:04 AM
KINGSLEY ALFRED DDirectorJun 14 '23Buy0.2130,0006,447469,111Jun 15 08:13 PM